Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $498.45 ($4.8M) on 2026-09-16, disclosed to the SEC on 2026-09-17.
Scheduled sale ($4.8M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $498.45 | 2,080 | $1.0M | 21.8% |
| 2 | $499.15 | 1,220 | $609K | 12.8% |
| 3 | $500.19 | 492 | $246K | 5.2% |
| 4 | $501.52 | 708 | $355K | 7.5% |
| 5 | $502.44 | 2,160 | $1.1M | 22.8% |
| 6 | $503.53 | 1,538 |
| $774K |
| 16.3% |
| 7 | $504.17 | 1,182 | $596K | 12.5% |
| 8 | $505.20 | 120 | $61K | 1.3% |
| Total | $501.39 avg | 9,500 | $4.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |